Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Schizophrenia [[electronic resource] /] / [edited by] Daniel R. Weinberger, Paul J. Harrison
| Schizophrenia [[electronic resource] /] / [edited by] Daniel R. Weinberger, Paul J. Harrison |
| Edizione | [3rd ed.] |
| Pubbl/distr/stampa | Chichester, West Sussex, UK, : Wiley-Blackwell, 2010 |
| Descrizione fisica | 1 online resource (746 p.) |
| Disciplina |
616.89/8
616.898 |
| Altri autori (Persone) |
WeinbergerDaniel R (Daniel Roy)
HarrisonP. J <1960-> (Paul J.) |
| Soggetto topico |
Schizophrenia
Psychiatry |
| ISBN |
1-4443-4774-8
1-283-20486-X 9786613204868 1-4443-2729-1 1-4443-2730-5 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Schizophrenia; Contents; Contributors; Editor ' s Note; Preface to the 3rd edition; Preface to the First Edition; PART 1: Descriptive Aspects; CHAPTER 1: Concept of schizophrenia: past, present, and future; CHAPTER 2: The schizophrenia construct: symptomatic presentation; CHAPTER 3: Child and adolescent schizophrenia; CHAPTER 4: Late - onset schizophrenia; CHAPTER 5: The schizophrenia spectrum personality disorders; CHAPTER 6: The prodrome of schizophrenia; CHAPTER 7: Course and outcome; CHAPTER 8: Neurocognitive impairments in schizophrenia: their character and role in symptom formation
PART 2: Biological AspectsCHAPTER 9: The secondary schizophrenias; CHAPTER 10: Schizophrenia: the epidemiological horizon; CHAPTER 11: Environmental risk factors for schizophrenia; CHAPTER 12: Classical genetic studies of schizophrenia; CHAPTER 13: Genetic associations in schizophrenia; CHAPTER 14: Intermediate phenotypes in genetic studies of schizophrenia; CHAPTER 15: Electrophysiology of schizophrenia; CHAPTER 16: Structural brain imaging in schizophrenia and related populations; CHAPTER 17: Functional brain imaging in schizophrenia; CHAPTER 18: Neuropathology of schizophrenia CHAPTER 19: Neurodevelopmental origins of schizophreniaCHAPTER 20: Dopamine and schizophrenia; CHAPTER 21: Contributions of glutamate and GABA systems to the neurobiology and treatment of schizophrenia; CHAPTER 22: Animal models of schizophrenia; PART 3: Physical Treatments; CHAPTER 23: Pharmacology and neuroscience of antipsychotic drugs; CHAPTER 24: Principles of pharmacological treatment in schizophrenia; CHAPTER 25: Comparative efficacy and effectiveness in the drug treatment of schizophrenia; CHAPTER 26: Approaches to treatment - resistant patients CHAPTER 27: Neurological complications of antipsychotic drugsCHAPTER 28: Metabolic adverse effects associated with antipsychotic medications; PART 4: Psychosocial Aspects; CHAPTER 29: Schizophrenia and psychosocial stresses; CHAPTER 30: Mental health services for patients with schizophrenia; CHAPTER 31: Societal outcomes in schizophrenia; CHAPTER 32: Psychological treatment of psychosis; CHAPTER 33: Economics of the treatment of schizophrenia; Index; colour plates |
| Record Nr. | UNINA-9910140881303321 |
| Chichester, West Sussex, UK, : Wiley-Blackwell, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Schizophrenia [[electronic resource] /] / [edited by] Daniel R. Weinberger, Paul J. Harrison
| Schizophrenia [[electronic resource] /] / [edited by] Daniel R. Weinberger, Paul J. Harrison |
| Edizione | [3rd ed.] |
| Pubbl/distr/stampa | Chichester, West Sussex, UK, : Wiley-Blackwell, 2010 |
| Descrizione fisica | 1 online resource (746 p.) |
| Disciplina |
616.89/8
616.898 |
| Altri autori (Persone) |
WeinbergerDaniel R (Daniel Roy)
HarrisonP. J <1960-> (Paul J.) |
| Soggetto topico |
Schizophrenia
Psychiatry |
| ISBN |
1-4443-4774-8
1-283-20486-X 9786613204868 1-4443-2729-1 1-4443-2730-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Schizophrenia; Contents; Contributors; Editor ' s Note; Preface to the 3rd edition; Preface to the First Edition; PART 1: Descriptive Aspects; CHAPTER 1: Concept of schizophrenia: past, present, and future; CHAPTER 2: The schizophrenia construct: symptomatic presentation; CHAPTER 3: Child and adolescent schizophrenia; CHAPTER 4: Late - onset schizophrenia; CHAPTER 5: The schizophrenia spectrum personality disorders; CHAPTER 6: The prodrome of schizophrenia; CHAPTER 7: Course and outcome; CHAPTER 8: Neurocognitive impairments in schizophrenia: their character and role in symptom formation
PART 2: Biological AspectsCHAPTER 9: The secondary schizophrenias; CHAPTER 10: Schizophrenia: the epidemiological horizon; CHAPTER 11: Environmental risk factors for schizophrenia; CHAPTER 12: Classical genetic studies of schizophrenia; CHAPTER 13: Genetic associations in schizophrenia; CHAPTER 14: Intermediate phenotypes in genetic studies of schizophrenia; CHAPTER 15: Electrophysiology of schizophrenia; CHAPTER 16: Structural brain imaging in schizophrenia and related populations; CHAPTER 17: Functional brain imaging in schizophrenia; CHAPTER 18: Neuropathology of schizophrenia CHAPTER 19: Neurodevelopmental origins of schizophreniaCHAPTER 20: Dopamine and schizophrenia; CHAPTER 21: Contributions of glutamate and GABA systems to the neurobiology and treatment of schizophrenia; CHAPTER 22: Animal models of schizophrenia; PART 3: Physical Treatments; CHAPTER 23: Pharmacology and neuroscience of antipsychotic drugs; CHAPTER 24: Principles of pharmacological treatment in schizophrenia; CHAPTER 25: Comparative efficacy and effectiveness in the drug treatment of schizophrenia; CHAPTER 26: Approaches to treatment - resistant patients CHAPTER 27: Neurological complications of antipsychotic drugsCHAPTER 28: Metabolic adverse effects associated with antipsychotic medications; PART 4: Psychosocial Aspects; CHAPTER 29: Schizophrenia and psychosocial stresses; CHAPTER 30: Mental health services for patients with schizophrenia; CHAPTER 31: Societal outcomes in schizophrenia; CHAPTER 32: Psychological treatment of psychosis; CHAPTER 33: Economics of the treatment of schizophrenia; Index; colour plates |
| Record Nr. | UNINA-9910831047203321 |
| Chichester, West Sussex, UK, : Wiley-Blackwell, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Schizophrenia / / [edited by] Daniel R. Weinberger, Paul J. Harrison
| Schizophrenia / / [edited by] Daniel R. Weinberger, Paul J. Harrison |
| Edizione | [3rd ed.] |
| Pubbl/distr/stampa | Chichester, West Sussex, UK, : Wiley-Blackwell, 2010 |
| Descrizione fisica | 1 online resource (746 p.) |
| Disciplina | 616.89/8 |
| Altri autori (Persone) |
WeinbergerDaniel R (Daniel Roy)
HarrisonP. J <1960-> (Paul J.) |
| Soggetto topico |
Schizophrenia
Psychiatry |
| ISBN |
1-4443-4774-8
1-283-20486-X 9786613204868 1-4443-2729-1 1-4443-2730-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Schizophrenia; Contents; Contributors; Editor ' s Note; Preface to the 3rd edition; Preface to the First Edition; PART 1: Descriptive Aspects; CHAPTER 1: Concept of schizophrenia: past, present, and future; CHAPTER 2: The schizophrenia construct: symptomatic presentation; CHAPTER 3: Child and adolescent schizophrenia; CHAPTER 4: Late - onset schizophrenia; CHAPTER 5: The schizophrenia spectrum personality disorders; CHAPTER 6: The prodrome of schizophrenia; CHAPTER 7: Course and outcome; CHAPTER 8: Neurocognitive impairments in schizophrenia: their character and role in symptom formation
PART 2: Biological AspectsCHAPTER 9: The secondary schizophrenias; CHAPTER 10: Schizophrenia: the epidemiological horizon; CHAPTER 11: Environmental risk factors for schizophrenia; CHAPTER 12: Classical genetic studies of schizophrenia; CHAPTER 13: Genetic associations in schizophrenia; CHAPTER 14: Intermediate phenotypes in genetic studies of schizophrenia; CHAPTER 15: Electrophysiology of schizophrenia; CHAPTER 16: Structural brain imaging in schizophrenia and related populations; CHAPTER 17: Functional brain imaging in schizophrenia; CHAPTER 18: Neuropathology of schizophrenia CHAPTER 19: Neurodevelopmental origins of schizophreniaCHAPTER 20: Dopamine and schizophrenia; CHAPTER 21: Contributions of glutamate and GABA systems to the neurobiology and treatment of schizophrenia; CHAPTER 22: Animal models of schizophrenia; PART 3: Physical Treatments; CHAPTER 23: Pharmacology and neuroscience of antipsychotic drugs; CHAPTER 24: Principles of pharmacological treatment in schizophrenia; CHAPTER 25: Comparative efficacy and effectiveness in the drug treatment of schizophrenia; CHAPTER 26: Approaches to treatment - resistant patients CHAPTER 27: Neurological complications of antipsychotic drugsCHAPTER 28: Metabolic adverse effects associated with antipsychotic medications; PART 4: Psychosocial Aspects; CHAPTER 29: Schizophrenia and psychosocial stresses; CHAPTER 30: Mental health services for patients with schizophrenia; CHAPTER 31: Societal outcomes in schizophrenia; CHAPTER 32: Psychological treatment of psychosis; CHAPTER 33: Economics of the treatment of schizophrenia; Index; colour plates |
| Record Nr. | UNINA-9910878090603321 |
| Chichester, West Sussex, UK, : Wiley-Blackwell, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||